The Column Group
Ms. Murakami joined The Column Group in 2008. She has worked in the financial industry for over thirty years with the last twenty years focused in venture capital. Most recently, she managed the state-side office of a Chinese venture capital firm in San Francisco and prior to that was Controller at a consulting firm in Cambridge, Massachusetts. Ms. Murakami earned a Bachelor’s degree at the University of Hawaii.
The Column Group
1 followers
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics.